ILLUMINA, INC. (ILMN)

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. The firm's products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray services, proactive instrument monitoring, and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

Address

5200 ILLUMINA WAY

SAN DIEGO, CA 92122

Founded

1998

Number of Employees

12,010

Website

http://www.illumina.com

Buyback

Buyback Data	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	Average
$ Amount Purchased ($ in 000s)	$243,150	$268,254	$249,305	$251	$201	$261	-	-	-	-	-	$126,904
Average Price	$160.67	$160.64	$134.82	$182.46	$320.89	$291.32	-	-	-	-	-	$151.21
# Shares Purchased	1,513,354	1,669,955	1,849,175	1,374	625	897	-	-	-	-	-	839,230

Buyback Performance	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	Average
Total Return to Date	-19.7%	-19.7%	-4.3%	-29.3%	-59.8%	-55.7%	-	-	-	-	-	-14.7%
S&P 500 Return to Date	181.9%	173.0%	168.6%	129.7%	104.9%	93.1%	-	-	-	-	-	141.9%
Excess Total Return	-201.6%	-192.7%	-172.9%	-159.0%	-164.7%	-148.8%	-	-	-	-	-	-156.5%
Quartile Rank
Percentile Rank	25%	26%	30%	23%	10%	10%	-	-	-	-	-	32%

Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.

Insider Transactions

Filters

Keyboard Shortcuts: Show (a) | Close (Esc)

People also followed

THERMO FISHER SCIENTIFIC INC.

VERTEX PHARMACEUTICALS INC / MA

STAPLEY MARC

ILLUMINA, INC.